161 related articles for article (PubMed ID: 12574948)
1. Bilateral subthalamic stimulation effects on oral force control in Parkinson's disease.
Pinto S; Gentil M; Fraix V; Benabid AL; Pollak P
J Neurol; 2003 Feb; 250(2):179-87. PubMed ID: 12574948
[TBL] [Abstract][Full Text] [Related]
2. Effect of bilateral subthalamic nucleus stimulation and dopatherapy on oral control in Parkinson's disease.
Gentil M; Tournier CL; Pollak P; Benabid AL
Eur Neurol; 1999; 42(3):136-40. PubMed ID: 10529538
[TBL] [Abstract][Full Text] [Related]
3. Treatment of tremor in Parkinson's disease by subthalamic nucleus stimulation.
Krack P; Benazzouz A; Pollak P; Limousin P; Piallat B; Hoffmann D; Xie J; Benabid AL
Mov Disord; 1998 Nov; 13(6):907-14. PubMed ID: 9827614
[TBL] [Abstract][Full Text] [Related]
4. Bilateral subthalamic nucleus stimulation for severe Parkinson's disease.
Limousin P; Pollak P; Benazzouz A; Hoffmann D; Broussolle E; Perret JE; Benabid AL
Mov Disord; 1995 Sep; 10(5):672-4. PubMed ID: 8552123
[TBL] [Abstract][Full Text] [Related]
5. Deep brain stimulation of the subthalamic nucleus for control of extrapyramidal features in advanced idiopathic parkinson's disease: one year follow-up.
Pinter MM; Alesch F; Murg M; Seiwald M; Helscher RJ; Binder H
J Neural Transm (Vienna); 1999; 106(7-8):693-709. PubMed ID: 10907728
[TBL] [Abstract][Full Text] [Related]
6. Effect of bilateral deep-brain stimulation on oral control of patients with parkinsonism.
Gentil M; Garcia-Ruiz P; Pollak P; Benabid AL
Eur Neurol; 2000; 44(3):147-52. PubMed ID: 11053962
[TBL] [Abstract][Full Text] [Related]
7. Levodopa-induced dyskinesias in Parkinson's disease: is sensitization reversible?
Bejjani BP; Arnulf I; Demeret S; Damier P; Bonnet AM; Houeto JL; Agid Y
Ann Neurol; 2000 May; 47(5):655-8. PubMed ID: 10805339
[TBL] [Abstract][Full Text] [Related]
8. Axial parkinsonian symptoms can be improved: the role of levodopa and bilateral subthalamic stimulation.
Bejjani BP; Gervais D; Arnulf I; Papadopoulos S; Demeret S; Bonnet AM; Cornu P; Damier P; Agid Y
J Neurol Neurosurg Psychiatry; 2000 May; 68(5):595-600. PubMed ID: 10766889
[TBL] [Abstract][Full Text] [Related]
9. Bilateral subthalamic stimulation for Parkinson's disease by using three-dimensional stereotactic magnetic resonance imaging and electrophysiological guidance.
Bejjani BP; Dormont D; Pidoux B; Yelnik J; Damier P; Arnulf I; Bonnet AM; Marsault C; Agid Y; Philippon J; Cornu P
J Neurosurg; 2000 Apr; 92(4):615-25. PubMed ID: 10761650
[TBL] [Abstract][Full Text] [Related]
10. Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson's disease.
Moro E; Scerrati M; Romito LM; Roselli R; Tonali P; Albanese A
Neurology; 1999 Jul; 53(1):85-90. PubMed ID: 10408541
[TBL] [Abstract][Full Text] [Related]
11. Short-term levodopa test assessed by movement time accurately predicts dopaminergic responsiveness in Parkinson's disease.
Zappia M; Montesanti R; Colao R; Branca D; Nicoletti G; Aguglia U; Quattrone A
Mov Disord; 1997 Jan; 12(1):103-6. PubMed ID: 8990062
[TBL] [Abstract][Full Text] [Related]
12. Long-term effect of electrostimulation of the subthalamic nucleus in bradykinetic-rigid Parkinson's disease.
Moringlane JR; Ceballos-Baumann AO; Alesch F
Minim Invasive Neurosurg; 1998 Sep; 41(3):133-6. PubMed ID: 9802035
[TBL] [Abstract][Full Text] [Related]
13. Effect of stimulation of the subthalamic nucleus on oral control of patients with parkinsonism.
Gentil M; Garcia-Ruiz P; Pollak P; Benabid AL
J Neurol Neurosurg Psychiatry; 1999 Sep; 67(3):329-33. PubMed ID: 10449555
[TBL] [Abstract][Full Text] [Related]
14. Speech dysfunction in early Parkinson's disease.
Stewart C; Winfield L; Hunt A; Bressman SB; Fahn S; Blitzer A; Brin MF
Mov Disord; 1995 Sep; 10(5):562-5. PubMed ID: 8552106
[TBL] [Abstract][Full Text] [Related]
15. Abnormal involuntary movements induced by subthalamic nucleus stimulation in parkinsonian patients.
Limousin P; Pollak P; Hoffmann D; Benazzouz A; Perret JE; Benabid AL
Mov Disord; 1996 May; 11(3):231-5. PubMed ID: 8723137
[TBL] [Abstract][Full Text] [Related]
16. Levodopa withdrawal after bilateral subthalamic nucleus stimulation in advanced Parkinson disease.
Molinuevo JL; Valldeoriola F; Tolosa E; Rumia J; Valls-Sole J; Roldan H; Ferrer E
Arch Neurol; 2000 Jul; 57(7):983-8. PubMed ID: 10891980
[TBL] [Abstract][Full Text] [Related]
17. Sequence heterogeneity in Parkinsonian speech.
Ho AK; Bradshaw JL; Cunnington R; Phillips JG; Iansek R
Brain Lang; 1998 Aug; 64(1):122-45. PubMed ID: 9675046
[TBL] [Abstract][Full Text] [Related]
18. Effect of bilateral subthalamic nucleus stimulation on gait in Parkinson's disease.
Faist M; Xie J; Kurz D; Berger W; Maurer C; Pollak P; Lücking CH
Brain; 2001 Aug; 124(Pt 8):1590-600. PubMed ID: 11459750
[TBL] [Abstract][Full Text] [Related]
19. Apomorphine test: a predictor for motor responsiveness to deep brain stimulation of the subthalamic nucleus.
Pinter MM; Alesch F; Murg M; Helscher RJ; Binder H
J Neurol; 1999 Oct; 246(10):907-13. PubMed ID: 10552237
[TBL] [Abstract][Full Text] [Related]
20. Chronic bilateral electrical stimulation of the subthalamic nucleus for the treatment of advanced Parkinson's disease.
Capus L; Melatini A; Zorzon M; Torre P; Carraro N; Moretti D; Gioulis M; Moretti R; Sarra MV; Marsala SZ
Neurol Sci; 2001 Feb; 22(1):57-8. PubMed ID: 11487200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
